Five-year Follow-up of Chronic Hepatitis B Patients Immunized by Nasal Route with the Therapeutic Vaccine HeberNasvac

A novel therapeutic vaccine for chronic hepatitis B (CHB) treatment comprising the recombinant hepatitis B surface (HBsAg) and nucleocapsid (HBcAg) antigens has been developed. Preclinical and clinical trials (CT) evidenced safety and immunogenicity in animal models as well as in phases I, II, and I...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Euroasian J Hepatogastroenterol
Asıl Yazarlar: Fernández, Guillermo, L Sanchez, Ana, Jerez, Everardo, E Anillo, Luis, Freyre, Freya, A Aguiar, Jorge, Leon, Yamila, Cinza, Zurina, A Diaz, Pablo, Figueroa, Nelvis, Muzio, Verena, G Nieto, Gerardo, Lobaina, Yadira, Aguilar, Arístides, Penton, Eduardo, C Aguilar, Julio
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Jaypee Brothers Medical Publishers 2018
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6395482/
https://ncbi.nlm.nih.gov/pubmed/30828555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5005/jp-journals-10018-1279
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller